Table 1.
Characteristics of nonfailing donor hearts and failing hearts
| Sample | Age | Sex | Diagnosis | LVEF | Treatment |
|---|---|---|---|---|---|
| Nonfailing | |||||
| NF1 | 26 | F | MVA | 70 | DP |
| NF2 | 38 | M | MVA | 70 | DP, EP, NE |
| NF3 | 52 | M | CVA | 45 | DP |
| NF4 | 29 | M | CVA | 50 | DZ, CD, EL, LP |
| NF5 | 69 | M | CVA | NA | DP, NE |
| NF6 | 46 | F | CVA | 70 | NE |
| NF8 | 52 | M | CVA | 85 | DP, TX |
| Failing | |||||
| F1 | 26 | M | DCM | 13 | DG |
| F2 | 49 | M | DCM | 20 | AD, CP, DG |
| F3 | 41 | M | DCM | 15 | AD, CP, DG, DT |
| F4 | 56 | M | DCM | 10 | AD, CP, DG, MN |
| F5 | 46 | M | DCM | 12 | AD, DG, LP, MN |
| F6 | 52 | M | DCM | 15 | CP, DG |
| F7 | 56 | M | DCM | 25 | AD, MN |
| F8 | 59 | M | DCM | 10 | AD, CP, DG, DT, MN |
LVEF, left ventricular ejection fraction; MVA, motor vehicle accident; CVA, cerebrovascular accident; DP, dopamine; EP, epinephrine; NE, norepinephrine; DZ, ditiazem; CD, clonidine; EL, enalapril; LP, lisinopril; TX, thyroxine; DG, digoxin; AD, amiodarone; CP, captopril; DT, dobutamine; MN, milrinone; LP, lisinopril.